Search results for "immunoglobulin"

showing 10 items of 841 documents

IgG Fc sialylation is regulated during the germinal center reaction following immunization with different adjuvants

2020

Background: Effector functions of IgG Abs are regulated by their Fc N-glycosylation pattern. IgG Fc glycans that lack galactose and terminal sialic acid residues correlate with the severity of inflammatory (auto)immune disorders and have also been linked to protection against viral infection and discussed in the context of vaccine-induced protection. In contrast, sialylated IgG Abs have shown immunosuppressive effects.Objective: We sought to investigate IgG glycosylation programming during the germinal center (GC) reaction following immunization of mice with a foreign protein antigen and different adjuvants.Methods: Mice were analyzed for GC T-cell, B-cell, and plasma cell responses, as wel…

Lipopolysaccharides0301 basic medicineGlycosylationT-LymphocytesFreund's AdjuvantPolysorbatesPlasma cellchemistry.chemical_compound0302 clinical medicineImmunology and AllergyMice KnockoutB-Lymphocytesbiologyddc:3. Good healthT follicular cellsIL-17medicine.anatomical_structureAlum CompoundsCytokinesFemaleAntibodySqualeneGlycosylationOvalbuminIgG glycosylationImmunologyAntibodiesIFN-gamma03 medical and health sciencesImmune systemAdjuvants ImmunologicAntigenmedicineAnimalsMineral OilAntigensIL-6IL-27RCord factorGerminal centerMycobacterium tuberculosisDendritic cellvaccinationMice Inbred C57BLcarbohydrates (lipids)030104 developmental biologychemistryadjuvantsgerminal centerImmunoglobulin GImmunologybiology.protein030215 immunologyJournal of Allergy and Clinical Immunology
researchProduct

Assessing the Cost of Mounting an Immune Response

2003

International audience; The evolution of parasite resistance has often been assumed to be governed by antagonistic selection pressures. Defense against pathogens, by mounting an immune response, confers evident benefits but may also incur costs, so that the optimal level of defense is expected to depend on the balance between benefits and costs. Although the benefits of immune surveillance are well known, estimates of costs are still equivocal. Here we studied the behavioral and physiological modifications associated with exposure to a onreplicating antigen (lipopolysaccharide [LPS] of Escherichia coli) in a passerine species, the house sparrow (Passer domesticus).We further investigated wh…

LipopolysaccharidesMale0106 biological sciencesLPSLitter SizeEcoimmunologyEnzyme-Linked Immunosorbent AssayTrade-off010603 evolutionary biology01 natural sciencesHost-Parasite InteractionsNesting BehaviorLife history theorySongbirds03 medical and health sciencesImmune systemAntigenbiology.animalEscherichia coliAnimalsEcology Evolution Behavior and Systematicstrade-off030304 developmental biologyparental effort[ SDE.BE ] Environmental Sciences/Biodiversity and Ecology0303 health sciencesbiologyReproductive successReproductionBody WeightFeeding BehaviorAntibodies BacterialBiological EvolutionBroodPasserinelife-history traitsparasite resistance[SDE.BE] Environmental Sciences/Biodiversity and Ecologyreproductive successImmunoglobulin Gtrade-off.ImmunologyFemale[SDE.BE]Environmental Sciences/Biodiversity and EcologyThe American Naturalist
researchProduct

Serum antibodies to Vibrio vulnificus biotype 3 lipopolysaccharide and susceptibility to disease caused by the homologous V. vulnificus biotype

2011

SUMMARYIn 1996 an outbreak of severe soft tissue infections caused byVibrio vulnificusunexpectedly erupted in fish consumers in Israel with relatively little morbidity in fish farmers. To test the hypothesis that recurrent exposure of fishermen to the virulent strain may have provided protection against severe or symptomatic disease, we investigated the association between the immune response toV. vulnificusbiotype 3 lipopolysaccharide (BT3 LPS) and disease susceptibility in fish farmers and fish consumers. Serum samples were tested for IgA and IgG of anti-BT3 LPS in fishermen and fish consumers who suffered fromV. vulnificusBT3 infections and their matched controls. Pre-existing levels of …

LipopolysaccharidesMaleSerumEpidemiologyVirulenceMicrobiologiaVibrio vulnificusImmunoglobulin GSerologyMicrobiologyVibrionaceaeVibrio Infectionsparasitic diseasesHumansIsraelVibrio vulnificusbiologyOutbreakMiddle Agedbiology.organism_classificationAntibodies BacterialImmunoglobulin AInfectious DiseasesCase-Control StudiesImmunoglobulin GVibrio InfectionsImmunologybiology.proteinFemaleDisease SusceptibilityAntibody
researchProduct

A role for Toll-like receptor mediated signals in neutrophils in the pathogenesis of the anti-phospholipid syndrome.

2012

The anti-phospholipid syndrome (APS) is characterized by recurrent thrombosis and occurrence of anti-phospholipid antibodies (aPL). aPL are necessary, but not sufficient for the clinical manifestations of APS. Growing evidence suggests a role of innate immune cells, in particular polymorphonuclear neutrophils (PMN) and Toll-like receptors (TLR) to be additionally involved. aPL activate endothelial cells and monocytes through a TLR4-dependent signalling pathway. Whether this is also relevant for PMN in a similar way is currently not known. To address this issue, we used purified PMN from healthy donors and stimulated them in the presence or absence of human monoclonal aPL and the TLR4 agonis…

LipopolysaccharidesNeutrophilsImmunology610 MedizinImmunoglobulinslcsh:MedicineInflammationApoptosisImmunopathologyBiologyNeutrophil ActivationAutoimmune DiseasesPhagocytosisimmune system diseases610 Medical sciencesmedicineHumansInterleukin 8L-SelectinReceptorlcsh:ScienceBiologyImmune ResponseneoplasmsRespiratory BurstInflammationToll-like receptorMultidisciplinaryInnate immune systemCD11b AntigenCoagulation DisordersEffectorInterleukin-8lcsh:RImmunityHematologyAntiphospholipid SyndromeFlow CytometryInnate ImmunityRespiratory burstToll-Like Receptor 4ImmunologyTLR4MedicineClinical Immunologylcsh:Qmedicine.symptomResearch ArticleSignal TransductionPLoS ONE
researchProduct

Clinical, immunological, and molecular analysis in a large cohort of patients with X-linked agammaglobulinemia: an Italian multicenter study

2002

A questionnaire-based retrospective clinical and immunological survey was conducted in 73 males with a definite diagnosis of X-linked agammaglobulinemia based on BTK sequence analysis. Forty-four were sporadic and 29 familial cases. At December 2000, the patients' ages ranged from 2 to 33 years; mean age at diagnosis and mean duration of follow-up were 3.5 and 10 years respectively. After the mid-1980s all but 2 were on intravenous immunoglobulin (IVIG) substitution therapy, with residual IgG >500 mg/dl in 94% of the patients at the time of enrollment. Respiratory infections were the most frequent manifestation both prior to diagnosis and over follow-up. Chronic lung disease (CLD) was prese…

Lung DiseasesAdultMalePediatricsmedicine.medical_specialtyGenetic Linkage; Agammaglobulinemia; Humans; Infant Newborn; Protein-Tyrosine Kinases; Child; Child Preschool; X Chromosome; Immunoglobulins Intravenous; Lung Diseases; Adult; Cohort Studies; Chronic Disease; Follow-Up Studies; Adolescent; Mutation; Maleclinical featuresX ChromosomeX-linked agammaglobulinemiaAdolescentGenetic LinkageImmunologyX-linked agammaglobulinemiaImmunoglobulinsX-linked agammaglobulinemia; infections; intravenous immunoglobulin; BTK mutationSepsisCohort StudiesAgammaglobulinemiaImmunopathologyintravenous immunoglobulinEpidemiologymedicineAgammaglobulinaemia Tyrosine KinaseImmunology and AllergyHumansinfectionsChildPreschoolSettore MED/38 - Pediatria Generale e SpecialisticaBTK mutationsbusiness.industryChronic sinusitisInfant NewbornMeningoencephalitisImmunoglobulins IntravenousInfantProtein-Tyrosine Kinasesmedicine.diseaseNewbornBTK mutationagammaglobulinemia; clinical features; BTK mutationsChild PreschoolChronic DiseaseMutationbusinessIntravenousMeningitisCohort studyFollow-Up Studies
researchProduct

Coincident airway exposure to low-potency allergen and cytomegalovirus sensitizes for allergic airway disease by viral activation of migratory dendri…

2019

Despite a broad cell-type tropism, cytomegalovirus (CMV) is an evidentially pulmonary pathogen. Predilection for the lungs is of medical relevance in immunocompromised recipients of hematopoietic cell transplantation, in whom interstitial CMV pneumonia is a frequent and, if left untreated, fatal clinical manifestation of human CMV infection. A conceivable contribution of CMV to airway diseases of other etiology is an issue that so far attracted little medical attention. As the route of primary CMV infection upon host-to-host transmission in early childhood involves airway mucosa, coincidence of CMV airway infection and exposure to airborne environmental antigens is almost unavoidable. For i…

Lung DiseasesPulmonologyMedizinCytomegalovirusImmunoglobulin EPathology and Laboratory MedicineWhite Blood CellsMiceAnimal CellsMedicine and Health SciencesCytotoxic T cellBiology (General)Enzyme-Linked ImmunoassaysImmune ResponseLung0303 health sciencesAntigen PresentationbiologyT Cells030302 biochemistry & molecular biologyAnimal Modelsrespiratory systemExperimental Organism SystemsFemalemedicine.symptomCellular TypesResearch ArticleQH301-705.5OvalbuminImmune CellsAntigen presentationImmunologyInflammationCytotoxic T cellsMouse ModelsResearch and Analysis MethodsMicrobiology03 medical and health sciencesSigns and SymptomsModel OrganismsTh2 CellsAntigenDiagnostic MedicineVirologyGeneticsmedicineHypersensitivityAnimalsT Helper CellsMolecular Biology TechniquesImmunoassaysMolecular Biology030304 developmental biologyInflammationBlood Cellsbusiness.industryCD11 AntigensBiology and Life SciencesCell BiologyDendritic CellsRC581-607Allergensrespiratory tract diseasesTransplantationMice Inbred C57BLOvalbuminDisease Models AnimalImmunologyRespiratory Infectionsbiology.proteinAnimal StudiesImmunologic TechniquesParasitologyVirus ActivationImmunologic diseases. AllergybusinessCD8CloningPLoS Pathogens
researchProduct

Use of intravenous immunoglobulins in Lyell syndrome: Experience of three cases

1996

We present our experience of treatment of the last three cases of Lyell syndrome we have observed. They are three female children, aged between 16 months and 3 years, who showed many features in common with severely burnt patients (large exuding lesions, severe reduction of circulating plasmatic volume, large denuded body surfaces, severe tendency to infections, ...). Therefore, together with the already known scheme of treatment (corticosteroids, correction of hydroelectrolitic balance, antimicrobials), we decided to use intravenous Immunoglobulins (IVIG), which had been already positively used in severely burnt patients. The favorable evolution of the affection in all three cases and the …

Lyell syndromeIntravenous Immunoglobulines (IVIG)Toxic Epidermal Necrolysis (TEN)
researchProduct

Evaluating polymicrobial immune responses in patients suffering from tick-borne diseases

2018

Abstract There is insufficient evidence to support screening of various tick-borne diseases (TBD) related microbes alongside Borrelia in patients suffering from TBD. To evaluate the involvement of multiple microbial immune responses in patients experiencing TBD we utilized enzyme-linked immunosorbent assay. Four hundred and thirty-two human serum samples organized into seven categories followed Centers for Disease Control and Prevention two-tier Lyme disease (LD) diagnosis guidelines and Infectious Disease Society of America guidelines for post-treatment Lyme disease syndrome. All patient categories were tested for their immunoglobulin M (IgM) and G (IgG) responses against 20 microbes assoc…

Lyme DiseaseCoinfectionco-infectionsBorrelialcsh:Rlcsh:MedicinezoonoositinfektiotCD57 AntigensImmunoglobulin MROC CurveTick-Borne DiseasesborrelioosiArea Under CurveBorrelia burgdorferiImmunoglobulin GimmuunivasteLymen borrelioosiHumanslcsh:Qlcsh:ScienceinfektiotauditScientific Reports
researchProduct

Deficient cytokine response of human allergen-specific T lymphocytes from humanized SCID mice and reconstitution by professional antigen-presenting c…

2000

Abstract Background: Hu-PBL-SCID mice generated by the transfer of PBMCs from atopic individuals may provide a physiologic in vivo model for investigating human responses to allergens and potential approaches toward immunotherapy. Objective: This study was undertaken to investigate the functional activity and cytokine profile of human allergen-reactive T lymphocytes isolated from hu-PBL-SCID mice. Methods: PBMCs from allergic individuals were coinjected with allergen into SCID mice. Human lymphocyte migration and phenotype were established by reverse transcription–PCR and immunohistochemistry, IgE levels in sera were determined, and the frequency of allergen-reactive cytokine-producing T ly…

Lymphoid Tissuemedicine.medical_treatmentT-LymphocytesImmunologyAntigen-Presenting CellsMice SCIDBiologyImmunoglobulin EEpitopesMiceImmune systemTh2 CellsCell MovementmedicineImmunology and AllergyAnimalsHumansInterferon gammaRNA MessengerAntigen-presenting cellInterleukin 5Cells CulturedT lymphocyteImmunotherapyAllergensImmunoglobulin ECytokineImmunologyAntibody Formationbiology.proteinCytokinesPeritoneumSpleenmedicine.drugThe Journal of allergy and clinical immunology
researchProduct

Clinical practice format for choosing a second-line disease modifying anti-rheumatic drug in early rheumatoid arthritis after failure of 6 months' fi…

2006

International audience; BACKGROUND: The objective was to develop a clinical practice format for choosing a second-line disease-modifying anti-rheumatic drug (DMARD) after a 6-month course of a first-line DMARD in patients with early RA. METHODS: A panel of 34 experts selected treatment option from various scenarios using the Thurstone pairwise method. The experts had to choose between two proposed DMARDs without proposing other options. The scenarios were obtained using the three items: DAS28, rheumatoid factor status and radiographic structural damage. A sample of 240 among 480 scenarios for each expert was taken at random. Responses given by at least 20% of the experts were considered per…

MESH: Antirheumatic AgentsMESH: Treatment FailureDiseaseReceptors Tumor Necrosis FactorEtanerceptArthritis Rheumatoid0302 clinical medicineMESH: Practice Guidelines as Topic030212 general & internal medicineTreatment Failureskin and connective tissue diseasesMESH: Immunoglobulin GMESH: Arthritis RheumatoidAnti rheumatic drugs3. Good healthClinical PracticeMESH: Methotrexate[SDV.MHEP.RSOA]Life Sciences [q-bio]/Human health and pathology/Rhumatology and musculoskeletal systemRheumatoid arthritisAntirheumatic AgentsPractice Guidelines as TopicDrug Therapy CombinationLeflunomidemusculoskeletal diseasesmedicine.medical_specialtyMESH: Rheumatoid FactorFirst lineMESH: Drug Administration ScheduleDrug Administration ScheduleDecision Support Techniques03 medical and health sciencesRheumatologyRheumatoid FactorDmard therapymedicineRheumatoid factorHumansIntensive care medicine030203 arthritis & rheumatologyMESH: HumansMESH: Sulfasalazinebusiness.industryMESH: Biological MarkersMESH: Decision Support TechniquesEarly rheumatoid arthritisIsoxazolesmedicine.diseaseMESH: Receptors Tumor Necrosis FactorRadiographySulfasalazineMESH: Drug Therapy CombinationMethotrexateMESH: IsoxazolesImmunoglobulin GPhysical therapybusinessBiomarkersJoint bone spine
researchProduct